Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Profiling oligosaccharidurias by electrospray tandem mass spectrometry: quantifying reducing oligosaccharides.

Ramsay SL, Meikle PJ, Hopwood JJ, Clements PR.

Anal Biochem. 2005 Oct 1;345(1):30-46.

PMID:
16111643
2.

Determination of oligosaccharides in Pompe disease by electrospray ionization tandem mass spectrometry.

Rozaklis T, Ramsay SL, Whitfield PD, Ranieri E, Hopwood JJ, Meikle PJ.

Clin Chem. 2002 Jan;48(1):131-9.

3.

Oligosaccharide analysis in urine by maldi-tof mass spectrometry for the diagnosis of lysosomal storage diseases.

Xia B, Asif G, Arthur L, Pervaiz MA, Li X, Liu R, Cummings RD, He M.

Clin Chem. 2013 Sep;59(9):1357-68. doi: 10.1373/clinchem.2012.201053. Epub 2013 May 15.

4.

HPLC analysis of oligosaccharides in urine from oligosaccharidosis patients.

Peelen GO, de Jong JG, Wevers RA.

Clin Chem. 1994 Jun;40(6):914-21.

5.

Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry.

Young SP, Stevens RD, An Y, Chen YT, Millington DS.

Anal Biochem. 2003 May 15;316(2):175-80.

PMID:
12711338
6.

Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases.

Ramsay SL, Maire I, Bindloss C, Fuller M, Whitfield PD, Piraud M, Hopwood JJ, Meikle PJ.

Mol Genet Metab. 2004 Nov;83(3):231-8.

PMID:
15542394
8.

Isolation and characterization of major urinary oligosaccharides excreted by a patient with type 3 GM1 gangliosidosis.

Tsuji S, Ariga T, Ando S, Tanaka Y, Kon K, Yahagi T, Ohta K, Miyatake T.

J Biochem. 1991 May;109(5):722-7.

9.

Analysis of keratan sulfate oligosaccharides by electrospray ionization tandem mass spectrometry.

Zhang Y, Kariya Y, Conrad AH, Tasheva ES, Conrad GW.

Anal Chem. 2005 Feb 1;77(3):902-10.

PMID:
15679360
11.

[Thin-layer chromatography of urine oligosaccharides in diagnosis of some lysosomal storage disorders].

Lugowska A, Tylki-Szymańska A, Sawnor-Korszyńska D.

Pediatr Pol. 1995 Oct;70(10):847-55. Polish.

PMID:
8649932
12.

A defect in exodegradative pathways provides insight into endodegradation of heparan and dermatan sulfates.

Fuller M, Chau A, Nowak RC, Hopwood JJ, Meikle PJ.

Glycobiology. 2006 Apr;16(4):318-25. Epub 2005 Dec 23.

PMID:
16377754
14.

Differentiation of isomeric oligosaccharide structures by ESI tandem MS and GC-MS.

Matamoros Fernández LE, Obel N, Scheller HV, Roepstorff P.

Carbohydr Res. 2004 Feb 25;339(3):655-64.

PMID:
15013403
15.
17.

Glycan profiling of urine, amniotic fluid and ascitic fluid from galactosialidosis patients reveals novel oligosaccharides with reducing end hexose and aldohexonic acid residues.

Bruggink C, Poorthuis BJ, Piraud M, Froissart R, Deelder AM, Wuhrer M.

FEBS J. 2010 Jul;277(14):2970-86. doi: 10.1111/j.1742-4658.2010.07707.x. Epub 2010 Jun 10.

19.

Site-specific N-glycosylation analysis of human plasma ceruloplasmin using liquid chromatography with electrospray ionization tandem mass spectrometry.

Harazono A, Kawasaki N, Itoh S, Hashii N, Ishii-Watabe A, Kawanishi T, Hayakawa T.

Anal Biochem. 2006 Jan 15;348(2):259-68. Epub 2005 Nov 10.

PMID:
16321355
20.

Determination of sialylated and neutral oligosaccharides in urine by mass spectrometry.

Clements PR.

Curr Protoc Hum Genet. 2012 Jan;Chapter 17:Unit17.10. doi: 10.1002/0471142905.hg1710s72.

PMID:
22241656

Supplemental Content

Support Center